Brief: Evolent Health Q1 Revenue USD 639.653 Million Vs. IBES Estimate USD 600.8 Million
09/05/2024 21:10
May 09 (Reuters) - Evolent Health Q1 net income USD -25.225 million vs. IBES estimate USD 28.6 million. * Q1 adjusted EBITDA margin 8.5% * Q1 adjusted EBITDA USD 54.097 million vs. IBES estimate USD 54.7 million * outlook FY adjusted EBITDA USD 235-265 million * outlook Q2 adjusted EBITDA USD 48-62 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows